These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1161615)

  • 1. [Fibrinogen and fibrin degradation products (FDP) in serum of patients with acute myocardial infarct and with imminent infarct].
    Kedra M; Kutarski A; Dmoxzyńska A
    Pol Tyg Lek; 1975 Sep; 30(37):1517-21. PubMed ID: 1161615
    [No Abstract]   [Full Text] [Related]  

  • 2. [Lipids and fibrin-fibrinogen degradation products levels in the serum in acute myocardial infarct].
    Kutarski A; Dmoszyńska A; Rymar B; Staśkiewicz J
    Pol Tyg Lek; 1976 Apr; 31(14):565-8. PubMed ID: 1272944
    [No Abstract]   [Full Text] [Related]  

  • 3. [Fibrin and fibrinogen degradation products (FDP) in relation to the extent of necrosis and some auxiliary tests in the diagnosis of myocardial infarct].
    Kutarski A; Dmoszyńska A; Staśkiewicz J
    Pol Tyg Lek; 1976 May; 31(16):655-8. PubMed ID: 1272961
    [No Abstract]   [Full Text] [Related]  

  • 4. [Fibrinogen and fibrin degradation products in serum and their prognostic significance in acute myocardial infarct].
    Krug H; Gryglik J; Jasiński K; Gluszek J
    Kardiol Pol; 1977; 20(1):9-14. PubMed ID: 846061
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunoenzyme determination of fibrin-fibrinogen degradation product levels in acute myocardial infarct patients].
    Grinshteĭn IA; Ignashenkova GV; Kitaev MI
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1987; 10(1):18-21. PubMed ID: 3300697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of antocoagulant treatment on the serum level of fibrinogen and fibrin degradation products in patients with threatened and actual myocardial infarct].
    Dmoszyńska A; Kowalewski J; Kutarski A
    Pol Tyg Lek; 1975 Oct; 30(40):1647-50. PubMed ID: 52152
    [No Abstract]   [Full Text] [Related]  

  • 7. [Fibrinogen and fibrin degradation products in the blood of acute myocardial infarct patients at the hospital rehabilitation stage].
    Solov'ev AV; Ermolin GA; Ignashenkova GV; Dikov MM
    Ter Arkh; 1987; 59(10):21-3. PubMed ID: 3324376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Early diagnosis of myocardial infarct. The determination of myoglobin and fibrin-degradation products in the blood serum].
    Orbetsov M; Milanov S; Stankusheva G; Sheĭretova E; Atanasov I
    Vutr Boles; 1986; 25(2):39-44. PubMed ID: 3716376
    [No Abstract]   [Full Text] [Related]  

  • 9. A study of soluble fibrin monomer complexes (SFMC) and plasma fibrinogen in acute myocardial infarction.
    Jain SM; Trivedi S
    Indian J Chest Dis Allied Sci; 1984; 26(2):98-103. PubMed ID: 6530267
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum fibrin/fibrinogen degradation products as a prognostic index in acute myocardial infarction.
    Samarendra-Lal-Choudhury ; Edge JR; Stansfield D
    J Clin Pathol; 1975 Oct; 28(10):821-4. PubMed ID: 1214016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrinolytic activity in coronary heart disease.
    Yao SK; Chen ZJ; Tao SQ
    Chin Med J (Engl); 1989 Sep; 102(9):660-3. PubMed ID: 2517077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The behaviour of fibrinogen and fibrinogen degradation products in myocardial infarction. Justification of a prognostic index (author's transl)].
    Abizanda Campos R; Forner Sánchez N; Carrió Soldevilla M; Florit Serra J
    Med Clin (Barc); 1979 Dec; 73(10):429-34. PubMed ID: 529865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Alterations of plasma plasminogen and fibrinogen, serum fibrin degradation products and degree of ADP induced platelet aggregation in acute myocardial infarction (author's transl)].
    Zhonghua Xin Xue Guan Bing Za Zhi; 1979; 7(1):49-52. PubMed ID: 550980
    [No Abstract]   [Full Text] [Related]  

  • 14. [The significance of changes in fibrinogen levels during thrombolytic therapy in myocardial infarct].
    Malý J; Pecka M; Pidrman V; Hamet A; Gregor J; Vodicka L; Siroký O; Tichý M
    Vnitr Lek; 1991 Mar; 37(3):229-37. PubMed ID: 2031311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinogen degradation products in acute myocardial infarction.
    Buch J
    Dan Med Bull; 1979 Jul; 26(4):206-8. PubMed ID: 487868
    [No Abstract]   [Full Text] [Related]  

  • 16. Specific identification of urinary fibrinogen, fibrinogen degradation products, and cross-linked fibrin degradation products in renal diseases and after renal allotransplantation.
    Scott WL; Francis CW; Knutson DW; Marder VJ
    J Lab Clin Med; 1986 Jun; 107(6):534-43. PubMed ID: 3519810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The detection of preventive hypofibronectinemia in diagnosing the development of disseminated intravascular coagulation in patients with myocardial infarction at the hospital rehabilitation stage].
    Solov'ev AV; Ermolin GA; Soroka VR
    Ter Arkh; 1993; 65(9):22-4. PubMed ID: 8303587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Preoperative determination of fibrin degradation products (FDP) in the sera of patients with suspected gynecologic tumors].
    Andersen HJ; Marushak A
    Ugeskr Laeger; 1985 May; 147(21):1689-91. PubMed ID: 4024309
    [No Abstract]   [Full Text] [Related]  

  • 19. [Level of fibrinogen/fibrin degradation products (F/FDP) in certain internal diseases].
    Alakhverdian R; Denchev K
    Vutr Boles; 1979; 18(4):28-32. PubMed ID: 494629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The content of fibronectin, fibrinogen, its degradation products and myoglobin in patients with ischemic heart disease].
    Malaia LT; Volkov VI; Topchiĭ II; Dykun IaV; Shuliak LN
    Ter Arkh; 1990; 62(11):87-90. PubMed ID: 2095000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.